Invega

See also: Generic Invega Sustenna

Invega is a brand name of paliperidone, approved by the FDA in the following formulation(s):

INVEGA (paliperidone - tablet, extended release; oral)

• 
  Manufacturer: JANSSEN PHARMS
  
  Approval date: December 19, 2006
  
  Strength(s): 3MG, 6MG ^[RLD], 9MG
  


• 
  Manufacturer: JANSSEN PHARMS
  
  Approval date: August 26, 2008
  
  Strength(s): 1.5MG
  

Has a generic version of Invega been approved?

No. There is currently no therapeutically equivalent version of Invega available.

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Invega. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Invega.

Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

• Exclusivity expiration dates:
  • December 19, 2011 - NEW CHEMICAL ENTITY
  
  
  • June 19, 2012 - PEDIATRIC EXCLUSIVITY
  
  
  • July 31, 2012 - TREATMENT OF SCHIZOAFFECTIVE DISORDER AS MONOTHERAPY
  
  
  • July 31, 2012 - ADJUNCT TO MOOD STABILIZERS AND/OR ANTIDEPRESSANTS FOR SCHIZOAFFECTIVE DISORDER
  
  
  • January 31, 2013 - PEDIATRIC EXCLUSIVITY
  
  
  • April 6, 2014 - NEW PATIENT POPULATION
  
  
  • October 6, 2014 - PEDIATRIC EXCLUSIVITY
  
  

See also...

• Invega Consumer Information (Drugs.com)
• Invega Extended-Release Tablets Consumer Information (Wolters Kluwer)
• Invega Consumer Information (Cerner Multum)
• Invega Advanced Consumer Information (Micromedex)
• Invega AHFS DI Monographs (ASHP)
• Paliperidone Consumer Information (Wolters Kluwer)
• Paliperidone Extended-Release Tablets Consumer Information (Wolters Kluwer)
• Paliperidone Consumer Information (Cerner Multum)
• Paliperidone Advanced Consumer Information (Micromedex)
• Paliperidone Intramuscular Advanced Consumer Information (Micromedex)
• Paliperidone AHFS DI Monographs (ASHP)